Khoo T, Lilleker JB, Thong BY et al (2023) Epidemiology of the idiopathic inflammatory myopathies. Nat Rev Rheumatol 19(11):695–712

Article  PubMed  Google Scholar 

Johnson C, Pinal-Fernandez I, Parikh R et al (2016) Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung 194(5):733–7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun K Y, Fan Y, Wang Y X et al (2021) Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020 [J]. Semin Arthritis Rheum 51(1):175–191

Article  PubMed  Google Scholar 

Decker P, Sobanski V, Moulinet T et al (2022) Interstitial pneumonia with autoimmune features: evaluation of connective tissue disease incidence during follow-up. Eur J Intern Med 97:62–8

Article  CAS  PubMed  Google Scholar 

Mb I, Deepak D, Bhatta A et al (2025) Prevalence of anti-synthetase syndrome in patients of interstitial lung disease with connective tissue diseases and autoimmune features: a cross-sectional study. Mediterr J Rheumatol 36(1):107–15

Article  PubMed  PubMed Central  Google Scholar 

SCIRè CA, Gonzalez-Gay MA, Selva-O’callaghan A et al (2017) Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies. Respir Med 132:265–6

Article  PubMed  Google Scholar 

Fischer A, West S G Swigrisjj et al (2010) Connective tissue disease-associated interstitial lung disease: a call for clarification [J]. Chest 138(2):251–256

Article  PubMed  PubMed Central  Google Scholar 

Kinder BW, Collard HR, Koth L et al (2007) Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176(7):691–7

Article  PubMed  PubMed Central  Google Scholar 

Vij R, Noth I, Strek ME (2011) Autoimmune-featured interstitial lung disease: a distinct entity. Chest 140(5):1292–9

Article  PubMed  PubMed Central  Google Scholar 

Fischer A, Antoniou KM, Brown KK et al (2015) An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46(4):976–87

Article  CAS  PubMed  Google Scholar 

Hallowell RW, Danoff SK (2023) Diagnosis and management of myositis-associated lung disease. Chest 163(6):1476–91

Article  CAS  PubMed  Google Scholar 

Lilleker JB, Vencovsky J, Wang G et al (2018) The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77(1):30–9

Article  PubMed  Google Scholar 

Hervier B, Meyer A, Dieval C et al (2013) Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. Eur Respir J 42(5):1271–82

Article  PubMed  Google Scholar 

Chua F, Higton A M, Colebatch A N et al (2012) Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort [J]. Rheumatology (Oxford) 51(10):1870–1876

Article  PubMed  Google Scholar 

Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA et al (2017) A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies [J]. Rheumatology (Oxford) 56(6):999–1007

Article  PubMed  PubMed Central  Google Scholar 

Wu W, Guo L, Fu Y et al (2021) Interstitial lung disease in anti-MDA5 positive dermatomyositis. Clin Rev Allergy Immunol 60(2):293–304

Article  CAS  PubMed  Google Scholar 

Chen Z, Cao M, Plana M N et al (2013) Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis [J]. Arthritis Care Res (Hoboken) 65(8):1316–1324

Article  CAS  PubMed  Google Scholar 

Ceribelli A, Fredi M, Taraborelli M et al (2014) Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis [J]. Clin Exp Rheumatol 32(6):891–897

PubMed  Google Scholar 

Marie I, Josse S, Hatron P Y et al (2013) Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome [J]. Arthritis Care Res (Hoboken) 65(5):800–808

Article  CAS  PubMed  Google Scholar 

Gono T, Sato S, Kawaguchi Y et al (2012) Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis [J]. Rheumatology (Oxford) 51(9):1563–1570

Article  CAS  PubMed  Google Scholar 

Koga T, Fujikawa K, Horai Y et al (2012) The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM [J]. Rheumatology (Oxford) 51(7):1278–1284

Article  CAS  PubMed  Google Scholar 

Tsuji H, Nakashima R, Hosono Y et al (2020) Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Arthritis Rheumatol 72(3):488–98

Article  CAS  PubMed  Google Scholar 

Lian X, Ye Y, Zou J et al (2023) Longitudinal study of patients with antimelanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease [J]. Rheumatology (Oxford) 62(5):1910–1919

Article  CAS  PubMed  Google Scholar 

Tomiyama F, Watanabe R, Ishii T et al (2016) High prevalence of acute exacerbation of interstitial lung disease in Japanese patients with systemic sclerosis. Tohoku J Exp Med 239(4):297–305

Article  CAS  PubMed  Google Scholar 

Muro Y, Sugiura K, Hoshino K et al (2011) Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan [J]. Arthritis Res Ther 13(6):R214

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishina N, Sato S, Masui K et al (2020) Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease. RMD Open. https://doi.org/10.1136/rmdopen-2020-001202

Article  PubMed  PubMed Central  Google Scholar 

So H, So J, Lam T T et al (2022) Seasonal Effect on Disease Onset and Presentation in Anti-MDA5 Positive Dermatomyositis [J]. Front Med (Lausanne) 9:837024

Article  PubMed  PubMed Central  Google Scholar 

Toquet S, Granger B, Uzunhan Y et al (2021) The seasonality of Dermatomyositis associated with anti-MDA5 antibody: An argument for a respiratory viral trigger [J]. Autoimmun Rev 20(4):102788

Article  CAS  PubMed  Google Scholar 

Wang G, Wang Q, Wang Y et al (2021) Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study. Front Immunol 12:791348

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang Se, Feng A, Meng W et al (2021) New-onset IgG autoantibodies in hospitalized patients with COVID-19 [J]. Nat Commun 12(1):5417

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Noumi B, Malik F et al (2023) A Rare Case of MDA-5-Positive Amyopathic Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Following COVID-19 mRNA Vaccination - a Case Report [J]. SN Compr Clin Med 5(1):18

Article  CAS